Grant: Discovery Grants Program - Individual
University of Calgary
$72,000.00
Epigenetic Regulation of Phenotypic Plasticity of Vascular Smooth Muscle Cells
FY 2024-25
Summary
Vascular smooth muscle cells (SMCs) are not terminally differentiated and have phenotypic plasticity: differentiated, contractile SMCs can undergo dedifferentiation and become synthetic and proliferative, and vice versa. Myocardin, a transcriptional coactivator of serum response factor (SRF), controls the expression of SMC contractile proteins and microRNAs (miRs) to promote SMC differentiation and inhibit cell proliferation. Many factors including hormones, growth factors and cytokines regulate SMC plasticity, but how they trigger intracellular signaling to confer phenotypic switching is poorly understood.
Evidence suggests that epigenetic modification participates in SMC phenotype regulation. DNA methylation, for example, inhibits myocardin gene expression. DNA methylation and demethylation are catalyzed by methyltransferases (DNMT1, 3A, 3B) and ten-eleven translocation (TET1, 2, 3) enzymes, respectively. Myocardin is associated with demethylation of its target genes, in which TET2 binds to CArG boxes in the promoters. However, the exact mechanisms underlying epigenetic regulation of SMC phenotypes remain largely unknown.
Rationale and hypothesis. Our preliminary results showed a role for DNA methylation in myocardin expression and functions. Our previous findings also revealed myocardin induction of miR-1 expression and inhibition of cell proliferation. Therefore, we hypothesize that myocardin gene methylation and demethylation determines myocardin gene expression and that myocardin also induces DNA demethylation of its target genes, driving SMC differentiation and inhibiting cell proliferation.
Objectives. To test the above hypotheses, we set up two aims over 5 years:
1) Investigate the roles for myocardin gene methylation and demethylation in SMC phenotypic plasticity. We expect to discover or reveal the specific DNMTs and TETs that dictate the DNA methylation level of the myocardin gene, contributing to the regulation of SMC phenotypic plasticity.
2) Determine how myocardin modulates DNA methylation of its target genes, including SM contractile proteins and miRs. We expect to reveal myocardin induction of demethylation of its target genes, such as SM contractile proteins and miRs, and the underlying mechanisms.
Significance. Our studies will uncover a novel epigenetic mechanism underlying SMC phenotypic plasticity, representing a major advancement in vascular biology.
Program
Discovery Grants Program - Individual
Recipient
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
RGPIN-2020-04592
Name nom
Zheng, Xi-Long
Department département
Biochemistry & Molecular Biology
Organization id
11
Institution établissement
University of Calgary
Province en
Alberta
Province fr
Alberta
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2024
Competition year année de concours
2020
Award amount
72000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
5105
Research subject group en
Cell biology
Research subject group fr
Biologie cellulaire
Research subject en
Cell differentiation
Research subject fr
Différenciation cellulaire
Field of research list names en
Not available
Field of research list names fr
Non disponible
Socioeconomic objective list names en
Not available
Socioeconomic objective list names fr
Non disponible
Application title
Epigenetic Regulation of Phenotypic Plasticity of Vascular Smooth Muscle Cells
Keywords
smooth muscle differentiation; smooth muscle dedifferentiation; phenotypic conversion; dna demethylation; dna methylation; myocardin; serum response factor; epigenetics; vascular remodeling; blood vessel formation
Application summary
Vascular smooth muscle cells (SMCs) are not terminally differentiated and have phenotypic plasticity: differentiated, contractile SMCs can undergo dedifferentiation and become synthetic and proliferative, and vice versa. Myocardin, a transcriptional coactivator of serum response factor (SRF), controls the expression of SMC contractile proteins and microRNAs (miRs) to promote SMC differentiation and inhibit cell proliferation. Many factors including hormones, growth factors and cytokines regulate SMC plasticity, but how they trigger intracellular signaling to confer phenotypic switching is poorly understood.
Evidence suggests that epigenetic modification participates in SMC phenotype regulation. DNA methylation, for example, inhibits myocardin gene expression. DNA methylation and demethylation are catalyzed by methyltransferases (DNMT1, 3A, 3B) and ten-eleven translocation (TET1, 2, 3) enzymes, respectively. Myocardin is associated with demethylation of its target genes, in which TET2 binds to CArG boxes in the promoters. However, the exact mechanisms underlying epigenetic regulation of SMC phenotypes remain largely unknown.
Rationale and hypothesis. Our preliminary results showed a role for DNA methylation in myocardin expression and functions. Our previous findings also revealed myocardin induction of miR-1 expression and inhibition of cell proliferation. Therefore, we hypothesize that myocardin gene methylation and demethylation determines myocardin gene expression and that myocardin also induces DNA demethylation of its target genes, driving SMC differentiation and inhibiting cell proliferation.
Objectives. To test the above hypotheses, we set up two aims over 5 years:
1) Investigate the roles for myocardin gene methylation and demethylation in SMC phenotypic plasticity. We expect to discover or reveal the specific DNMTs and TETs that dictate the DNA methylation level of the myocardin gene, contributing to the regulation of SMC phenotypic plasticity.
2) Determine how myocardin modulates DNA methylation of its target genes, including SM contractile proteins and miRs. We expect to reveal myocardin induction of demethylation of its target genes, such as SM contractile proteins and miRs, and the underlying mechanisms.
Significance. Our studies will uncover a novel epigenetic mechanism underlying SMC phenotypic plasticity, representing a major advancement in vascular biology.